Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

ArriVent Biopharma Stock

arrivent.comHealthcareFounded: 2021Funding to Date: $260MM

ArriVent Biopharma is a drug development platform that sources oncology therapies from around the world and drives them through the approval process.

Buy or sell ArriVent Biopharma stock Learn more about ArriVent Biopharma IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for ArriVent Biopharma.

Register Today

Other companies like ArriVent Biopharma in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions